REQUEST A DEMO
Total
USD $0.00
Search more companies

Biolidics Limited (Singapore)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Biolidics Limited Profile Updated: August 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Biolidics Limited (Formerly known as Clearbridge BioMedics), formerly known as Biolidics Limited (Formerly known as Clearbridge BioMedics), is a Singapore-based company. The company develops diagnostic solutions using patented microfluidic biochip technology, with a focus on the healthcare industry. Their main business includes the development and commercialization of the ClearCell FX1 System, a fully automated IVD medical device that separates and enriches cancer cells from blood. The company is also exploring technology-enabled lifestyle businesses.

Headquarters
37 Jalan Pemimpin, 02-07 Mapex
Singapore; Singapore; Postal Code: 577177

Contact Details: Purchase the Biolidics Limited report to view the information.

Website: http://www.biolidics.com

Basic Information
Total Employees:
Purchase the Biolidics Limited report to view the information.
Outstanding Shares:
Purchase the Biolidics Limited report to view the information.
Financial Auditors:
Purchase the Biolidics Limited report to view the information.
Incorporation Date:
2009
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
13.23%
Purchase this report to view the information.
11.14%
Subsidiaries
Biolidics Limited
100%
Biomedics Laboratory Pte. Ltd.
100%
Clearbridge Japan Co., Ltd
100%
Company Performance
Financial values in the chart are available after Biolidics Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-95.15%
Total operating revenue
-89.44%
Operating profit (EBIT)
-26.83%
EBITDA
-48.91%
Net Profit (Loss) for the Period
-52.21%
Total assets
-84.46%
Total equity
-49.62%
Operating Profit Margin (ROS)
-1865.56%
Net Profit Margin
-2418.75%
Return on Equity (ROE)
1.03%
Debt to Equity Ratio
98.09%
Quick Ratio
-0.66%
Cash Ratio
-0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?